Description
Class C07J : STEROIDS
Subclass 33/00: Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton
C07J 33/00
Sub-Class
Stats
- 30 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- 8 Total Patent Owners
- 110 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12252582 | Biofunctional thiophene monomers and polymers thereof for electronic biomedical devices | Aug 28, 20 | Mar 18, 25 | The University of Delaware |
| 12227537 | Intermediates for the preparation of 11-methylene steroids | May 13, 21 | Feb 18, 25 | CRYSTAL PHARMA, S.A.U. |
| 12077559 | Process for the preparation of 3α-hydroxy-5α-pregnan-20-one (brexanolone) | Oct 21, 19 | Sep 03, 24 | Industriale Chimica S.R.L. |
| 11945836 | Compositions and methods for treating CNS disorders | Oct 04, 22 | Apr 02, 24 | SAGE THERAPEUTICS, INC. |
| 11667667 | Steroid derivative FXR agonist | Oct 13, 20 | Jun 06, 23 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD, |
| 11479577 | Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid | Feb 26, 21 | Oct 25, 22 | NZP UK Limited |
| 11344563 | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof | Jul 10, 19 | May 31, 22 | SAGE THERAPEUTICS, INC. |
| 11044931 | Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof | Jul 29, 19 | Jun 29, 21 | BASF SE |
| 11034716 | Process and new intermediates for the preparation of 11-methylene steroids | Mar 02, 17 | Jun 15, 21 | CRYSTAL PHARMA, S.A.U. |
| 10968250 | Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid | May 18, 17 | Apr 06, 21 | NZP UK Limited |
| 10875888 | Steroid derivative FXR agonist | Jan 25, 17 | Dec 29, 20 | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD, |
| 10774108 | Compositions and methods for treating CNS disorders | Nov 27, 15 | Sep 15, 20 | SAGE THERAPEUTICS, INC. |
| 10398159 | Low molecular weight modulators of the cold menthol receptor TRPM8 and use thereof | Jun 01, 17 | Sep 03, 19 | BASF SE |
| 10391106 | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof | Jun 30, 17 | Aug 27, 19 | SAGE THERAPEUTICS, INC. |
| 10308676 | Methods of making onapristone intermediates | Sep 23, 16 | Jun 04, 19 | CONTEXT BIOPHARMA INC. |
| 10093694 | Compounds for treating eye disorders or diseases | Feb 02, 17 | Oct 09, 18 | GUANGZHOU KANGRUI BIOLOGICAL PHARMACEUTICAL TECHNOLOGY CO, LTD.; The Regents of the University of California; |
| 9725481 | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof | Apr 17, 14 | Aug 08, 17 | SAGE THERAPEUTICS, INC. |
| 9464108 | Combined synthesis route for desogestrel and etonogestrel | Mar 13, 13 | Oct 11, 16 | MERCK SHARP & DOHME B.V. |
| 6117994 | Intermediates for 16.beta.-methyl steroids | Apr 22, 98 | Sep 12, 00 | AVENTIS PHARMA S.A. |
| 6043235 | 11.beta.-aryl-17, 17-spirothiolane-substituted steroids | Jul 21, 99 | Mar 28, 00 | RESEARCH TRIANGLE INSTITUTE |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2025/0042,934 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | Feb 20, 24 | Feb 06, 25 | Not available |
| 2024/0218,011 | GLUCOCORTICOID RECEPTOR AGONISTS AND CONJUGATES THEREOF | Jul 20, 23 | Jul 04, 24 | Not available |
| 2022/0402,965 | STEROL ANALOGS AND USES THEREOF | Sep 19, 19 | Dec 22, 22 | Not available |
| 2021/0277,050 | OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISORDERS | Jun 18, 19 | Sep 09, 21 | CELLIX BIO PRIVATE LIMITED |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 27 Months (last 2 years Issuances)
- 27 Months (last 5 years Issuances)